Specialty Pharma Journal Specialty, Precision & Technology
BOISE, Idaho, May 31, 2017 /PRNewswire/ — Albertsons Companies announced today that it recently acquired MedCart Specialty Pharmacy in order to strengthen and extend its pharmacy specialty services. MedCart Specialty Pharmacy is an industry-leading, URAC accredited, pharmaceutical and healthcare provider of customized specialty care services and medication management for patients …
Breaking News
- MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys’s Novel Immuno-Oncology Agent MOR210
- Agios Presents Updated Data from Phase 1 Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma
- AstraZeneca Provides Update on the Phase 3 Trial of Imfinzi and tremelimumab in Stage IV Non-Small Cell Lung Cancer
- Immunicum Collaborates with Merck KGaA and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study
- Identification of LZTR1 Leads to Novel Insights into RAS-Driven Diseases
- Mission Therapeutics and AbbVie Sign DUBs Collaboration in Alzheimer’s and Parkinson’s Disease
- uniQure Announces Initial Topline Data from Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B
- FDA Grants Breakthrough Therapy Designation to Seattle Genetics’ Adcetris for Frontline Peripheral T-Cell Lymphomas
- Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Arena’s Investigational PAH Drug Ralinepag
- Blueprint Medicines’ Avapritinib Demonstrates Positive Results in Clinical Trial in Patients with Advanced Gastrointestinal Stromal Tumors